FOS and neoplasm: As for the dominant-negative c-Jun, A-Fos activity has been evaluated by transgenic expression of the dominant-negative c-Fos derivative in a skin carcinogenesis system, in which A-Fos prevents the development of squamous lesions by inducing transdifferentiation into sebaceous tumors [92].